149,651 Shares in LifeStance Health Group, Inc. $LFST Purchased by Moran Wealth Management LLC

Moran Wealth Management LLC purchased a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 149,651 shares of the company’s stock, valued at approximately $953,000.

A number of other large investors also recently bought and sold shares of the stock. Larson Financial Group LLC boosted its position in LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after purchasing an additional 3,791 shares in the last quarter. Bayesian Capital Management LP acquired a new stake in shares of LifeStance Health Group during the 2nd quarter worth approximately $52,000. Krane Funds Advisors LLC purchased a new position in shares of LifeStance Health Group during the 4th quarter valued at approximately $71,000. Cibc World Markets Corp purchased a new position in shares of LifeStance Health Group during the 4th quarter valued at approximately $77,000. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of LifeStance Health Group during the 3rd quarter valued at approximately $78,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at LifeStance Health Group

In other news, Director Darren M. Black sold 5,899,661 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the completion of the sale, the director owned 23,310,115 shares of the company’s stock, valued at $186,947,122.30. The trade was a 20.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Robert Bessler sold 894,337 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $10.13, for a total transaction of $9,059,633.81. Following the transaction, the director owned 539,763 shares of the company’s stock, valued at approximately $5,467,799.19. This trade represents a 62.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 7,762,394 shares of company stock valued at $64,107,859 over the last ninety days. Corporate insiders own 6.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on LFST. Wall Street Zen raised shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a report on Saturday. JPMorgan Chase & Co. lifted their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Thursday, May 14th. Jefferies Financial Group upgraded shares of LifeStance Health Group to a “strong-buy” rating in a research report on Thursday, March 12th. The Goldman Sachs Group started coverage on shares of LifeStance Health Group in a research note on Friday, June 5th. They set a “neutral” rating and a $9.00 target price on the stock. Finally, Zacks Research upgraded LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, April 27th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $9.75.

LifeStance Health Group Price Performance

Shares of LFST stock traded up $0.06 during trading hours on Tuesday, hitting $11.04. 287,218 shares of the company’s stock were exchanged, compared to its average volume of 3,338,566. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.18. The firm has a market cap of $4.28 billion, a P/E ratio of 183.92 and a beta of 1.12. The firm has a 50 day moving average of $8.40 and a two-hundred day moving average of $7.43. LifeStance Health Group, Inc. has a fifty-two week low of $3.74 and a fifty-two week high of $11.62.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. The firm had revenue of $403.48 million for the quarter, compared to analysts’ expectations of $387.46 million. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The company’s quarterly revenue was up 21.2% compared to the same quarter last year. Sell-side analysts forecast that LifeStance Health Group, Inc. will post 0.12 EPS for the current year.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.